TY - STD TI - WHO Regional Office for the Eastern Mediterranean. Country Cooperation Strategy for WHO and Kuwait 2012–2016. Nasr City, Cairo 11371, Egypt: World Health Organization. (Country Cooperation Strategy (CCS)); 2014. Available from: http://apps.who.int/iris/bitstream/handle/10665/113231/CCS_Kuwait_2014_EN_15234.pdf. [cited 2019 Mar 28]. UR - http://apps.who.int/iris/bitstream/handle/10665/113231/CCS_Kuwait_2014_EN_15234.pdf ID - ref1 ER - TY - STD TI - Central Intelligence Agency. The world Factbook. Available from: https://www.cia.gov/library/publications/the-world-factbook/geos/ku.html. [cited 2019 Mar 28]. UR - https://www.cia.gov/library/publications/the-world-factbook/geos/ku.html ID - ref2 ER - TY - STD TI - Kuwait Central Statistical Bureau. Population statistics. Available from: https://csb.gov.kw/Pages/Statistics_en?ID=67&ParentCatID=1. [cited 2019 Mar 28]. UR - https://csb.gov.kw/Pages/Statistics_en?ID=67&ParentCatID=1 ID - ref3 ER - TY - STD TI - Al Hussaini M, Alsaffar N, Abdulraheem A. Exploring community pharmacists’ knowledge, perception and experiences towards branded and generic medicines in Kuwait: highlighting the role of pharmacist. Bull Fac Pharm Cairo Univ. 2018;56(1):109–114. Available from: http://www.sciencedirect.com/science/article/pii/S1110093118300061. [cited 2019 Mar 28]. UR - http://www.sciencedirect.com/science/article/pii/S1110093118300061 ID - ref4 ER - TY - STD TI - Alfonso-Christancho R, Andia T, Barbosa T, Watanabe JH. Definition and classification of generic drugs across the world. Appl Health Econ Health Policy. 2015; Supplement. Available from: https://link.springer.com/article/10.1007/s40258-014-0146-1. [cited 2019 Mar 28]. UR - https://link.springer.com/article/10.1007/s40258-014-0146-1 ID - ref5 ER - TY - STD TI - Gothe H, Schall I, Saverno K, Mitrovic M, Luzak A, Brixner D, et al. The impact of generic substitution on health and economic outcomes: a systematic review. Appl Health Econ Health Policy. 2015;13(1):21–33. Available from: http://link.springer.com/article/10.1007/s40258-014-0147-0. [cited 2019 Mar 28]. UR - http://link.springer.com/article/10.1007/s40258-014-0147-0 ID - ref6 ER - TY - STD TI - Gallelli L, Mumoli L, Palleria C, Piro B, Russo E, Vasapollo P, et al. Safety and efficacy of generic drugs with respect to brand formulation. J Pharmacol Pharmacother. 2013;4(5):110. Available from: http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2013;volume=4;issue=5;spage=110;epage=114;aulast=Gallelli. [cited 2019 Mar 28]. UR - http://www.jpharmacol.com/article.asp?issn=0976-500X;year=2013;volume=4;issue=5;spage=110;epage=114;aulast=Gallelli ID - ref7 ER - TY - JOUR AU - Johnston, A. AU - Holt, D. W. PY - 2014 DA - 2014// TI - Substandard drugs: a potential crisis for public health JO - Br J Clin Pharmacol VL - 78 UR - https://doi.org/10.1111/bcp.12298 DO - 10.1111/bcp.12298 ID - Johnston2014 ER - TY - JOUR AU - Bate, R. AU - Jin, G. Z. AU - Mathur, A. PY - 2011 DA - 2011// TI - Does price reveal poor-quality drugs? Evidence from 17 countries JO - J Health Econ VL - 30 UR - https://doi.org/10.1016/j.jhealeco.2011.08.006 DO - 10.1016/j.jhealeco.2011.08.006 ID - Bate2011 ER - TY - STD TI - Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8(12). Available from: https://doi.org/10.1371/journal.pmed.1001139. [cited 2019 Mar 28]. UR - https://doi.org/10.1371/journal.pmed.1001139 ID - ref10 ER - TY - STD TI - Brixner D, Maniadakis N, Kaló Z, Hu S, Shen J, Wijaya K. Considering Multicriteria Decision Analysis (MCDA) Simple Scoring as an Evidence-Based HTA Methodology for Evaluating Off-Patent Pharmaceuticals (OPPs) in Emerging Markets. Value Health Reg Issues. 2017;13c:1–6. Available from: http://www.valuehealthregionalissues.com/article/S2212-1099(17)30001-8/fulltext. [cited 2019 Mar 28]. UR - http://www.valuehealthregionalissues.com/article/S2212-1099(17)30001-8/fulltext ID - ref11 ER - TY - JOUR AU - Kaló, Z. AU - Holtorf, A. -. P. AU - Alfonso-Cristancho, R. AU - Shen, J. AU - Ágh, T. AU - Inotai, A. PY - 2015 DA - 2015// TI - Need for multicriteria evaluation of generic drug policies JO - Value Health J Int Soc Pharmacoeconomics Outcomes Res VL - 18 UR - https://doi.org/10.1016/j.jval.2014.12.012 DO - 10.1016/j.jval.2014.12.012 ID - Kaló2015 ER - TY - STD TI - Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, et al. Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health. 2016;19(1):1–13. Available from: https://doi.org/10.1016/j.jval.2015.12.003. [cited 2019 Mar 28]. ID - ref13 ER - TY - JOUR AU - Mühlbacher, A. C. AU - Kaczynski, A. PY - 2016 DA - 2016// TI - Making good decisions in healthcare with multi-criteria decision analysis: the use, current research and future development of MCDA JO - Appl Health Econ Health Policy VL - 14 UR - https://doi.org/10.1007/s40258-015-0203-4 DO - 10.1007/s40258-015-0203-4 ID - Mühlbacher2016 ER - TY - JOUR AU - Kolasa, K. AU - Zah, V. AU - Kowalczyk, M. PY - 2018 DA - 2018// TI - How can multi criteria decision analysis support value assessment of pharmaceuticals? - findings from a systematic literature review JO - Expert Rev Pharmacoecon Outcomes Res VL - 18 UR - https://doi.org/10.1080/14737167.2018.1467759 DO - 10.1080/14737167.2018.1467759 ID - Kolasa2018 ER - TY - STD TI - Hu S, Zhang Y, He J, Du L, Xu M, Xie C, et al. A case study of pharmaceutical pricing in China: setting the Price for off-patent originators. Appl Health Econ Health Policy. 2015;13(1):13–20. Available from: http://link.springer.com/article/10.1007/s40258-014-0150-5. [cited 2019 Mar 28]. UR - http://link.springer.com/article/10.1007/s40258-014-0150-5 ID - ref16 ER - TY - STD TI - Tuan PL, Tuan Kiet PH, Brixner DI, Ngo VH. Development of multiple criteria decision analysis framework for off-patent pharmaceuticals decision making in Vietnam | European chamber of commerce in Vietnam [internet]. Hanoi, Vietnam: European chamber of commerce Vietnam; 2017. Available from: https://www.eurochamvn.org/node/16937. [cited 2019 Mar 28]. UR - https://www.eurochamvn.org/node/16937 ID - ref17 ER - TY - STD TI - Brixner D, Maniadakis N, Kaló Z, Kim K, Wijaya K. An Evidence Framework for Off-Patent Pharmaceutical Review (EFOR) for Health Technology Assessment in Emerging Markets. Value Health Reg Issues. 2018;16c:9–13. Available from: https://doi.org/10.1016/j.vhri.2018.01.003. [cited 2019 Mar 28]. UR - https://doi.org/10.1016/j.vhri.2018.01.003 ID - ref18 ER - TY - STD TI - Assawamakin A, Holtorf A-P, Maniadakis N. Weighing Price and performance for decisions for multisource pharmaceutical bidding in public hospitals in Thailand. In: Reddy S, editor. Evaluation of health programs. London: INTECH Open Access Publisher; 2019. p. 14. Available from: https://www.intechopen.com/online-first/weighing-price-and-performance-for-decisions-for-multisource-pharmaceutical-bidding-in-public-hospit. [cited 2019 Mar 28]. UR - https://www.intechopen.com/online-first/weighing-price-and-performance-for-decisions-for-multisource-pharmaceutical-bidding-in-public-hospit ID - ref19 ER - TY - JOUR AU - Inotai, A. AU - Nguyen, H. T. AU - Hidayat, B. AU - Nurgozhin, T. AU - Kiet, P. H. T. AU - Campbell, J. D. PY - 2018 DA - 2018// TI - Guidance towards the implementation of multi-criteria decision analysis framework in developing countries JO - Expert Rev Pharmacoecon Outcomes Res. VL - 18 UR - https://doi.org/10.1080/14737167.2018.1508345 DO - 10.1080/14737167.2018.1508345 ID - Inotai2018 ER - TY - STD TI - Communities and Local Government. Multi-criteria analysis: a manual. Wetherby, Great Britain: Department for Communities and Local Government; 2009. Available from: http://www.communities.gov.uk/documents/corporate/pdf/1132618.pdf. [cited 2019 Mar 28]. UR - http://www.communities.gov.uk/documents/corporate/pdf/1132618.pdf ID - ref21 ER - TY - STD TI - Inotai A, Brixner D, Maniadakis N, Dwiprahasto I, Kristin E, Prabowo A, et al. Development of multi-criteria analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia. BMS Health Serv Res. 2018;18(1003) (online). Available from: https://doi.org/10.1186/s12913-018-3805-3. [cited 2019 Mar 28]. ID - ref22 ER - TY - STD TI - Hu S, Holtorf A-P, Wijaya K, He J, Brixner D. Value based evaluation for health insurance policy schemes in China’s provinces. In: Reddy S, editor. Evaluation of health programs [internet]. London: INTECH Open Access Publisher; 2019. Available from: https://www.intechopen.com/online-first/value-based-evaluation-of-chinese-provincial-health-insurance-policy-schemes. [cited 2019 Mar 28]. UR - https://www.intechopen.com/online-first/value-based-evaluation-of-chinese-provincial-health-insurance-policy-schemes ID - ref23 ER -